Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Redefining vitamin D insufficiency.

Malabanan A, Veronikis IE, Holick MF.

Lancet. 1998 Mar 14;351(9105):805-6. No abstract available.

PMID:
9519960
2.

When is Vitamin D contraindicated in dialysis patients?

Martin KJ.

Semin Dial. 2009 May-Jun;22(3):247-9. doi: 10.1111/j.1525-139X.2009.00566.x. Review. No abstract available.

PMID:
19573001
3.

When is Vitamin D contraindicated in dialysis patients?

Khosla N, Sprague SM.

Semin Dial. 2009 May-Jun;22(3):249-51. doi: 10.1111/j.1525-139X.2009.00567.x. Review. No abstract available.

PMID:
19573002
4.

When is Vitamin D Contraindicated in Dialysis Patients?

Goodman WG.

Semin Dial. 2009 May-Jun;22(3):245-7. doi: 10.1111/j.1525-139X.2009.00565.x. Review. No abstract available.

PMID:
19573000
5.

Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D.

McKenna MJ, Freaney R.

Osteoporos Int. 1998;8 Suppl 2:S3-6. Review. No abstract available.

PMID:
10197175
6.

Role of vitamin d receptor activators in cardio-renal syndromes.

Cozzolino M, Bruschetta E, Stucchi A, Ronco C, Cusi D.

Semin Nephrol. 2012 Jan;32(1):63-9. doi: 10.1016/j.semnephrol.2011.11.009. Review.

PMID:
22365164
7.

[Vitamin D therapy in predialysis renal failure].

Ando R.

Clin Calcium. 2004 Sep;14(9):73-7. Review. Japanese.

PMID:
15577115
8.

When is Vitamin D contraindicated in dialysis patients?

Evenepoel P.

Semin Dial. 2009 May-Jun;22(3):242-4. doi: 10.1111/j.1525-139X.2009.00564.x. Review. No abstract available.

PMID:
19572999
9.

Effect of nutritional vitamin D preparations on parathyroid hormone in patients with chronic kidney disease.

Pipili C, Dimitriadis C, Sekercioglu N, Bargman JM, Oreopoulos DD.

Int Urol Nephrol. 2012 Feb;44(1):167-71. doi: 10.1007/s11255-011-0048-1. Epub 2011 Aug 26. Review. No abstract available.

PMID:
21870088
10.

[Vitamin D deficiency and supplementation in the elderly. A comparative trial of various modalities of administrating vitamin D2].

Sebert JL, Fardellone P, Liu S, Ruiz JC, Bellony R, Cohen-Solal M, Perdu V, Defrance D.

Rev Rhum Mal Osteoartic. 1988 Jul-Sep;55(9):693-700. Review. French. No abstract available.

PMID:
3055249
11.

Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D.

Maeda SS, Borba VZ, Camargo MB, Silva DM, Borges JL, Bandeira F, Lazaretti-Castro M; Brazilian Society of Endocrinology and Metabology (SBEM).

Arq Bras Endocrinol Metabol. 2014 Jul;58(5):411-33. English, Portuguese.

12.
13.

Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs.

Brancaccio D, Cozzolino M, Galassi A, Chiarelli G, Butti A, Bellasi A, Rocca-Rey L, Volpi A, Anelli A, Zoni U, Fusaro M, Brambilla C, Missaglia E, Crovetto C, Russo M, Longhini C, Provenzano R, Incalcaterra F, Cerasola G, Li Vecchi M, Gallieni M.

J Nephrol. 2007 Jan-Feb;20(1):3-9. Review.

PMID:
17347966
14.

Paricalcitol capsules for the control of secondary hyperparathyroidism in chronic kidney disease.

Cheng S, Coyne D.

Expert Opin Pharmacother. 2006 Apr;7(5):617-21. Review.

PMID:
16553577
15.

The contribution of nutritional factors to osteopenia in the elderly.

Sahota O, Hosking DJ.

Curr Opin Clin Nutr Metab Care. 2001 Jan;4(1):15-20. Review.

PMID:
11122554
16.

Spotlight on paricalcitol in secondary hyperparathyroidism.

Robinson DM, Scott LJ.

Treat Endocrinol. 2005;4(3):185-6. Review.

PMID:
15898824
17.

Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.

Sprague SM, Coyne D.

Clin J Am Soc Nephrol. 2010 Mar;5(3):512-8. doi: 10.2215/CJN.03850609. Epub 2010 Feb 4. Review.

18.
19.

Improved patient outcomes in chronic kidney disease: optimizing vitamin D therapy.

Gesek FA, Desmond JS.

Nephrol Nurs J. 2008 Mar-Apr;35(2 Suppl):5S-22S; quiz 23S. Review.

PMID:
18505229
20.

Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease.

Andress DL, Coyne DW, Kalantar-Zadeh K, Molitch ME, Zangeneh F, Sprague SM.

Endocr Pract. 2008 Jan-Feb;14(1):18-27. Review.

PMID:
18238737

Supplemental Content

Support Center